vs
ASP Isotopes Inc.(ASPI)与BIOLIFE SOLUTIONS INC(BLFS)财务数据对比。点击上方公司名可切换其他公司
BIOLIFE SOLUTIONS INC的季度营收约是ASP Isotopes Inc.的1.1倍($18.8M vs $16.7M),ASP Isotopes Inc.同比增速更快(1295.7% vs 24.3%)
ASP Isotopes Inc.是一家特种材料企业,专注于高纯度定制同位素的研发与生产,产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域,客户覆盖北美、欧洲及亚太地区。
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案,服务于细胞与基因治疗、生物制药及再生医学领域,产品涵盖低温保存培养基、自动化解冻系统、温度监测工具,为全球相关企业、科研机构及临床实验室提供支持。
ASPI vs BLFS — 直观对比
营收规模更大
BLFS
是对方的1.1倍
$16.7M
营收增速更快
ASPI
高出1271.3%
24.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.7M | $18.8M |
| 净利润 | — | $11.1M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | 7.2% |
| 净利率 | — | 58.9% |
| 营收同比 | 1295.7% | 24.3% |
| 净利润同比 | -586.8% | -11.1% |
| 每股收益(稀释后) | — | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASPI
BLFS
| Q4 25 | $16.7M | $18.8M | ||
| Q3 25 | $4.9M | $28.1M | ||
| Q2 25 | — | $25.4M | ||
| Q1 25 | — | $23.9M | ||
| Q4 24 | — | $15.1M | ||
| Q3 24 | — | $21.4M | ||
| Q2 24 | — | $19.7M | ||
| Q1 24 | — | $18.4M |
净利润
ASPI
BLFS
| Q4 25 | — | $11.1M | ||
| Q3 25 | $-12.9M | $621.0K | ||
| Q2 25 | — | $-15.8M | ||
| Q1 25 | — | $-448.0K | ||
| Q4 24 | — | $12.5M | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-20.7M | ||
| Q1 24 | — | $-10.2M |
毛利率
ASPI
BLFS
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
ASPI
BLFS
| Q4 25 | — | 7.2% | ||
| Q3 25 | -306.1% | -0.3% | ||
| Q2 25 | — | -65.5% | ||
| Q1 25 | — | -5.1% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -2.0% | ||
| Q2 24 | — | -6.6% | ||
| Q1 24 | — | -17.9% |
净利率
ASPI
BLFS
| Q4 25 | — | 58.9% | ||
| Q3 25 | -263.7% | 2.2% | ||
| Q2 25 | — | -62.3% | ||
| Q1 25 | — | -1.9% | ||
| Q4 24 | — | 82.5% | ||
| Q3 24 | — | -8.0% | ||
| Q2 24 | — | -105.1% | ||
| Q1 24 | — | -55.4% |
每股收益(稀释后)
ASPI
BLFS
| Q4 25 | — | $0.23 | ||
| Q3 25 | $-0.15 | $0.01 | ||
| Q2 25 | — | $-0.33 | ||
| Q1 25 | — | $-0.01 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $33.0M |
| 总债务越低越好 | $14.4M | $5.0M |
| 股东权益账面价值 | $204.2M | $371.9M |
| 总资产 | $498.0M | $405.9M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
ASPI
BLFS
| Q4 25 | $333.3M | $33.0M | ||
| Q3 25 | $113.9M | $29.5M | ||
| Q2 25 | — | $31.9M | ||
| Q1 25 | — | $66.9M | ||
| Q4 24 | — | $91.5M | ||
| Q3 24 | — | $24.0M | ||
| Q2 24 | — | $22.0M | ||
| Q1 24 | — | $29.7M |
总债务
ASPI
BLFS
| Q4 25 | $14.4M | $5.0M | ||
| Q3 25 | $13.9M | $7.5M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $12.9M | ||
| Q4 24 | — | $15.9M | ||
| Q3 24 | — | $20.1M | ||
| Q2 24 | — | $21.1M | ||
| Q1 24 | — | $24.3M |
股东权益
ASPI
BLFS
| Q4 25 | $204.2M | $371.9M | ||
| Q3 25 | $74.1M | $353.7M | ||
| Q2 25 | — | $347.2M | ||
| Q1 25 | — | $352.6M | ||
| Q4 24 | — | $348.9M | ||
| Q3 24 | — | $325.5M | ||
| Q2 24 | — | $321.4M | ||
| Q1 24 | — | $333.4M |
总资产
ASPI
BLFS
| Q4 25 | $498.0M | $405.9M | ||
| Q3 25 | $225.9M | $392.1M | ||
| Q2 25 | — | $387.2M | ||
| Q1 25 | — | $395.1M | ||
| Q4 24 | — | $399.5M | ||
| Q3 24 | — | $381.7M | ||
| Q2 24 | — | $375.0M | ||
| Q1 24 | — | $401.6M |
负债/权益比
ASPI
BLFS
| Q4 25 | 0.07× | 0.01× | ||
| Q3 25 | 0.19× | 0.02× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $4.9M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.44× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ASPI
BLFS
| Q4 25 | $-37.8M | $4.9M | ||
| Q3 25 | $-8.9M | $6.1M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | — | $-4.5M |
自由现金流
ASPI
BLFS
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
ASPI
BLFS
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
ASPI
BLFS
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
ASPI
BLFS
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 9.83× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图